BIOGEN INC. Stockholders Equity

Quick Answer

BIOGEN INC. reported Stockholders Equity of $14.80 billion for the year ending 2023.

  • BIOGEN INC. showed an increase of +10.5% in Stockholders Equity from 2022 to 2023.
  • This data is from BIOGEN INC.'s annual report (Form 10-K), filed with the SEC on February 14, 2024.
  • XBRL data for this metric is available from 2008 to 2023 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2009: $6.25 billion | Q3 2009: $6.56 billion | Q1 2010: $5.91 billion | Q2 2010: $5.17 billion | Q3 2010: $5.03 billion | Q1 2011: $5.60 billion | Q2 2011: $5.98 billion | Q3 2011: $6.23 billion | Q1 2012: $6.31 billion | Q2 2012: $6.27 billion | Q3 2012: $6.66 billion | Q1 2013: $7.34 billion | Q2 2013: $7.90 billion | Q3 2013: $8.13 billion | Q1 2014: $9.14 billion | Q2 2014: $9.56 billion | Q3 2014: $10.43 billion | Q1 2015: $11.67 billion | Q2 2015: $12.57 billion | Q3 2015: $10.57 billion | Q1 2016: $10.33 billion | Q2 2016: $11.40 billion | Q3 2016: $12.12 billion | Q1 2017: $11.48 billion | Q2 2017: $11.59 billion | Q3 2017: $12.86 billion | Q1 2018: $14.05 billion | Q2 2018: $12.26 billion | Q3 2018: $13.77 billion | Q1 2019: $13.83 billion | Q2 2019: $12.95 billion | Q3 2019: $14.00 billion | Q1 2020: $12.55 billion | Q2 2020: $11.31 billion | Q3 2020: $10.76 billion | Q1 2021: $10.68 billion | Q2 2021: $10.75 billion | Q3 2021: $10.43 billion | Q1 2022: $11.24 billion | Q2 2022: $11.87 billion | Q3 2022: $12.78 billion | Q1 2023: $13.80 billion | Q2 2023: $14.47 billion | Q3 2023: $14.48 billion.
  • Over the full 16 years of available data (2008 to 2023), BIOGEN INC.'s Stockholders Equity has grown by 154.9%.
  • Historical annual values: Fiscal year 2023: $14.80 billion | Fiscal year 2022: $13.40 billion | Fiscal year 2021: $10.90 billion | Fiscal year 2020: $10.70 billion | Fiscal year 2019: $13.34 billion | Fiscal year 2018: $13.04 billion | Fiscal year 2017: $12.61 billion | Fiscal year 2016: $12.14 billion | Fiscal year 2015: $9.37 billion | Fiscal year 2014: $10.81 billion | Fiscal year 2013: $8.62 billion | Fiscal year 2012: $6.96 billion | Fiscal year 2011: $6.43 billion | Fiscal year 2010: $5.40 billion | Fiscal year 2009: $6.22 billion | Fiscal year 2008: $5.81 billion.
  • Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: